SG
Steven Gannon

Steven Gannon insider trades: Xenon Pharmaceuticals (XENE) stock buys and sales

Xenon Pharmaceuticals Last trade Aug 11, 2026 26 Form 4 filings
$641K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2017
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Steven reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 11, 2026XENE↓ Sell$641K
Jun 5, 2025XENE↓ Sell$91
Mar 7, 2024XENE↓ Sell$602K
Aug 11, 2022FUSN↑ Buy$90K
Aug 23, 2021FUSN↑ Buy$23K
Aug 19, 2021FUSN↑ Buy$26K
Aug 16, 2021FUSN↑ Buy$49K
Aug 11, 2017XENE↑ Buy$42K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other XENE insiders

Open-market trades in the last 12 months

About Steven Gannon's insider trades

Steven Gannon is an insider at Xenon Pharmaceuticals (XENE). Since Aug 11, 2017, Steven has reported 5 open-market purchases worth $229K and 3 sales worth $1.2M on SEC Form 4. In the last 12 months: 1 sale ($641K).

Their filings also include grants and awards (16 filings), option exercises (3 filings), shares withheld for taxes (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XENE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.